A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
for Prostate Cancer
1 location in Hackensack
Sponsor: Regeneron Pharmaceuticals
Sex: Male·Age: 18+
Code: NCT07543055·Phase 1·Recruiting·Listed Apr 2026